JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

THE THERAPEUTIC POTENTIAL OF STIMULATING ENDOGENOUS STEM CELL MOBILIZATION.

The past few years have seen extensive interest in treatment of various diseases with adult stem cells (ASC). This paper will not discuss umbilical cord or adipose tissue derived stem cells, but rather peripheral blood stem cells (PBSC). We will demonstrate that one of the natural roles of stem cells is to participate in tissue repair both due to injury or degenerative disease. We will review the mechanisms involved with stem cell release and activation and present two new natural triggers for this release and possible differentiation. The clinical relevance of mobilizing endogenous bone marrow derived stem cells would be to increase the number migrating into damaged organs, becoming affective cells and contributing to tissue repair. This approach overcomes the problems of growing autologous stem cell cultures and their implantation. It also may release other progenitor cells that appears to be playing a vital role in organ regeneration. We present examples of tissue repair using these new modalities. Part of this paper was first presented at the international conference of acupuncture and electrotherapeutics held at Columbia University Oct. 2013. Since then the field has exploded and we will try to include some of the most relevant discoveries.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app